5th Dec 2007 11:46
Skyepharma PLC05 December 2007 For Immediate Release 5 December 2007 SkyePharma PLC ("the Company") The Company was informed on 4 December 2007 that as a result of transactions on4 December 2007 by the SkyePharma PLC Share Purchase Plan (an approved allemployee share purchase plan) the Trustees of the Plan purchased an additional10,488 Ordinary Shares of the Company at a price of 13.25 pence per share. Following these transactions, the Trustees hold on behalf of the Plan, 149,927Ordinary Shares representing 0.018% of the share capital of the Company. Theclass of discretionary beneficiaries for whom the Trustees hold such sharesconsists of employees of the Company, including the following ExecutiveDirectors: Frank Condella and Peter Grant. As a result of these transactions, the following Executive Directors have thefollowing additional interests as a result of their personal participation inthe Plan:- Partnership Shares Matching Shares Total number of purchased on awarded on Partnership and 4 December 2007 4 December 2007 Matching Shares at 13.25p per share at 13.25p per share held on 4 December 2007 Frank Condella 943 943 21,122Peter Grant 943 943 13,750 In accordance with the rules of the Plan these Directors have been awardedMatching Shares on the basis of one Matching Share (Ordinary Share) for eachPartnership Share (Ordinary Share). The beneficial ownership of the Matching Shares will pass to the Directors inthree years' time subject to continued employment and the retention of theunderlying Partnership Shares. The execution of the transaction noted above did not involve any of theCompany's Directors or any persons discharging managerial responsibility. This notification relates to transactions notified in accordance withDisclosure and Transparency Rule 3.1.4R(1)(a). This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
SKP.L